Immuno-Biological Laboratories Co (TSE:4570) Institutional Ownership: 0.06% (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4570 Immuno-Biological Laboratories Co Ltd TSE:4570
59 GF Score
Price 円996.00
GF Value 円586.95
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Immuno-Biological Laboratories Co Institutional Ownership?

Immuno-Biological Laboratories Co TSE:4570 +5.96% 59 Institutional Ownership is 0.06% as of Aug. 12, 2026. GuruFocus rates TSE:4570 with a GF Score™ of 59/100 and a GF Value™ of 円586.95 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immuno-Biological Laboratories Co's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immuno-Biological Laboratories Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immuno-Biological Laboratories Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Immuno-Biological Laboratories Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Immuno-Biological Laboratories Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuno-Biological Laboratories Co Institutional Ownership Chart

Immuno-Biological Laboratories Co Historical Data

The historical data trend for Immuno-Biological Laboratories Co can be seen below:

2020-01-31 2020-02-29 2020-03-31 2020-04-30 2020-05-31 2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31
Institutional Ownership 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
TSE:4570
59GF Score
Immuno-Biological Laboratories Co Ltd TSE:4570
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immuno-Biological Laboratories Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.06% mean?
Immuno-Biological Laboratories Co (TSE:4570) has a Institutional Ownership of 0.06% as of Aug. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Immuno-Biological Laboratories Co and its competitors.
Is Immuno-Biological Laboratories Co's Institutional Ownership too high?
Immuno-Biological Laboratories Co's current Institutional Ownership is 0.06%. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Institutional Ownership compare to VRTX and REGN?
Immuno-Biological Laboratories Co's Institutional Ownership of 0.06% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Immuno-Biological Laboratories Co and its competitors. Immuno-Biological Laboratories Co's current Institutional Ownership is 0.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円586.95, compared to a current price of 円996.00 — trading 69.7% above its estimated fair value. The current Institutional Ownership is 0.06%. Immuno-Biological Laboratories Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Institutional Ownership is 0.06% as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?

Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued. The current stock price of 円996.00 is trading 69.7% above its estimated GF Value™ of 円586.95. GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.

Key valuation signals for TSE:4570:

  • Institutional Ownership: 0.06%
  • GF Value™: 円586.95 vs. price of 円996.00 (69.7% above fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immuno-Biological Laboratories Co Business Description

Address 1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
59GF Score

Get the complete analysis for TSE:4570

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円996.00
Price
円586.95
GF Value